课题基金 / 基金详情

Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.

Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization.
Syk 和 Rac2 在 HIF1α 和新血管形成调节中的作用。
批准号:
7844911
负责人:
DONALD DURDEN
金额:
$23.18万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-06 至 2011-06-30

项目摘要

项目成果

DONALD DURDEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The process of postnatal neovascularization plays a crucial role in pathogenesis of numerous diseases e.g. diabetic retinopathy, tissue remodeling upon injury, rheumatoid arthritis and tumor growth/metastasis. It has been known that endothelial cells (ECs) and its micro environment is the key for regulation of neovascularization/angiogenesis. However, the signal transduction events underlying this complex process are not well understood. The objective of this proposal is to gain insight the regulatory network in ECs for HIF11 accumulation and neovascularization. Our preliminary genetic analysis of Syk-/+ or Syk-/+; Rac2-/+ mice reveal a requirement of Syk for integrin induced activation of Rac2 and hypoxia induced stabilization of HIF11. We hypothesize that Syk-Vav1-Rac2 signaling axis exists in ECs and plays an obligate role in neovascularization via HIF11 stabilization. Preliminary data from our laboratory also suggest that specific region of Syk (Y342 and Y346 at B linker region, those are cognate binding sites for Vav and PLC3 respectively) appear to be involved in the activation of Rac2 but not Rac1 downstream of integrin signaling and migration. We propose in our Aim1 to determine Syk-Rac2 signaling axis a possible focal point for HIF11 stabilization. In Aim 2 we propose to evaluate the role of Syk-Rac2 signaling axis in postnatal neovascularization. Considering the importance of postnatal neovascularization, the identification of a novel molecular pathway, Syk-Vav1-Rac2 signaling axis, will result in the development of innovative therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
  • 批准号:
    9828553
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    DONALD DURDEN
  • 依托单位:
Role of PTEN and PI-3 kinase in medulloblastomagenesis
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
海外基金